Zee Media Bureau
Mumbai: Sun Pharmaceutical Industries Ltd is in talks to buy Sweden's Meda AB for over USD 5 billion, a news wire has reported.
Sun Pharma has reported a 23.32 percent increase in consolidated net profit for the January-March quarter.
The pharma company’s stocks last traded down 2.54% at Rs 1,045.50 for the week ended yesterday.
Mumbai-based Sun is India's most valuable drugmaker, with a market capitalisation of some USD 20 billion, and has made several acquisitions in recent years.
With Agency Inputs
First Published: Saturday, June 1, 2013, 09:08